Egan James 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Dec 16, 2010
Insider Transaction Report
Form 4
Egan James
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2010-12-08+80,000→ 80,000 totalExercise: $3.68Exp: 2020-12-08→ Class A common stock (80,000 underlying)
Footnotes (1)
- [F1]Commencing on December 8, 2011, the first anniversary of the original grant date, the option vests annually with respect to 25% of the aggregate option share total.